Author

R. Starr

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Organism:mouse· 1

Frequent Co-Authors

B. Aguilar· 3 shared B. Badie· 3 shared D. Alizadeh· 3 shared D. Wang· 3 shared A. Brito· 2 shared C. E. Brown· 2 shared J. R. Ostberg· 2 shared S. J. Forman· 2 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

B. Aguilar

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Selective IL13Rα2-Targeted Functionality of IL13-Ligand CARs is Enhanced by Inclusion of 4-1BB Co-Stimulation

R. Starr, X. Yang, B. Aguilar, D. Gumber, S. Huard, D. Wang, W.-C. Chang, A. Brito, V. Chiu, J. R. Ostberg, B. Badie, S. J. Forman, D. Alizadeh, L. D. Wang, C. E. Brown

This study compares IL13-ligand CAR designs to determine how co-stimulation domains affect tumor selectivity and anti-tumor activity against glioblastoma.

bioRxiv · Mar 30, 2022 · PreprintImmunology

CAR T cell therapy drives endogenous locoregional T cell dynamics in a responding patient with glioblastoma

V. D. Jonsson, R. Ng, N. Dullerud, R. A. Wong, J. Hibbard, D. Wang, B. Aguilar, R. Starr, L. Weng, D. Alizadeh, S. Forman, B. Badie, C. E. Brown

This study tracks T cell dynamics in a glioblastoma patient undergoing CAR T cell therapy, showing endogenous T cells are activated and contribute to treatment response.

bioRxiv · Sep 22, 2021 · PreprintImmunology

Chlorotoxin Redirects Chimeric Antigen Receptor T Cells for Specific and Effective Targeting of Glioblastoma

D. Wang, R. Starr, W.-C. Chang, B. Aguilar, D. Alizadeh, S. L. Wright, X. Yang, A. Brito, A. Sarkissian, J. R. Ostberg, Y. Shi, M. Gutova, K. Aboody, B. Badie, S. J. Forman, , C. Brown

This study develops a CAR T cell therapy using chlorotoxin to target glioblastoma with high specificity and potency, overcoming tumor heterogeneity challenges.

bioRxiv · Jan 24, 2020 · PreprintImmunology